Burning Rock Biotech Limited
BNR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $132 | $149 | $133 | $126 |
| % Growth | -11.4% | 11.6% | 5.6% | – |
| Cost of Goods Sold | $33 | $40 | $36 | $37 |
| Gross Profit | $99 | $108 | $97 | $89 |
| % Margin | 75.1% | 72.8% | 73.2% | 71% |
| R&D Expenses | $41 | $50 | $40 | $52 |
| G&A Expenses | $32 | $31 | $31 | $37 |
| SG&A Expenses | $74 | $70 | $72 | $84 |
| Sales & Mktg Exp. | $42 | $38 | $41 | $47 |
| Other Operating Expenses | $0 | $0 | $0 | $35 |
| Operating Expenses | $115 | $120 | $113 | $171 |
| Operating Income | -$16 | -$11 | -$15 | -$82 |
| % Margin | -12.3% | -7.7% | -11.4% | -65% |
| Other Income/Exp. Net | -$0 | $2 | $2 | $6 |
| Pre-Tax Income | -$17 | -$9 | -$13 | -$76 |
| Tax Expense | $0 | $0 | $0 | $5 |
| Net Income | -$17 | -$10 | -$14 | -$81 |
| % Margin | -12.7% | -6.5% | -10.1% | -64.5% |
| EPS | -15.6 | -9 | -12.5 | -78.7 |
| % Growth | -73.3% | 28% | 84.1% | – |
| EPS Diluted | -15.6 | -9 | -12.5 | -78.7 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $3 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $13 | $13 | $0 | $0 |
| EBITDA | -$3 | $1 | -$15 | -$47 |
| % Margin | -2.5% | 0.9% | -11.4% | -37.1% |